Julie Glowacki, PhD, is director of skeletal biology at Brigham and Women’s Hospital (BWH), Professor of Orthopedic Surgery at Harvard Medical School, and Professor of Oral and Maxillofacial Surgery at Harvard School of Dental Medicine. She received her BA in biology, chemistry, and philosophy from Boston University and her PhD in biological chemistry from Harvard University.


Glowacki’s research, which has been funded by the National Institutes of Health, the Department of Defense, NOAA, and various foundations, concerns mechanisms of congenital and acquired musculoskeletal disorders and their treatment. She has edited or co-authored more than 200 articles, books, and chapters concerning original basic, translational, and clinical research on skeletal development, growth, pathology, and aging, and on innovative approaches to skeletal reconstruction—including two books Biologic Foundations for Skeletal Tissue Engineering and The Aging Skeleton.


Glowacki holds eight patents on aspects of skeletal tissue engineering. She has served as a voting member of a U.S. FDA panel, a consultant to NASA and the U.S. Centers for Medicare and Medicaid Services, a board member of numerous scientific journals, and advisor to national and international organizations.  Currently, she serves on the Harvard Medical School Conflicts-of-Interest Committee and NIH review panels. She has received many honors and awards for research contributions, community service, and for training and mentoring aspiring scientists.